BIOLASE Inc Stock Nasdaq
Equities
US0909111082
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 51.5M | Sales 2025 * | 55.5M | Capitalization | 4.88M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.09 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-0.47
x | P/E ratio 2025 * |
-1.36
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on BIOLASE Inc
Managers | Title | Age | Since |
---|---|---|---|
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director of Finance/CFO | 53 | 21-01-31 | |
Steven Sandor
COO | Chief Operating Officer | 44 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Lord
CHM | Chairman | 69 | 14-07-31 |
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director/Board Member | 73 | 21-08-15 |
1st Jan change | Capi. | |
---|---|---|
+7.65% | 209B | |
+9.03% | 175B | |
+10.95% | 131B | |
+18.60% | 99.98B | |
-0.95% | 61.12B | |
+14.48% | 52.34B | |
-4.15% | 46.5B | |
-0.83% | 39.24B | |
+11.28% | 38.47B |